¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Syndrome, acute brain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • Laurence-Moon syndrome
    ·Î·»½º-¹®ÁõÈıº
  • Lennox-Gastaut syndrome
    ·¹³ì½º-°¡½ºÅäÁõÈıº
  • Lesch-Nyhan syndrome
    ·¹½´-´ÏÇÑÁõÈıº
  • Libman-Sacks syndrome
    ¸®ºê¸Õ-»è½ºÁõÈıº
  • locked-in syndrome
    °¨±ÝÁõÈıº
  • long QT syndrome
    ±äQTÁõÈıº
  • lymphadenopathy syndrome
    ¸²ÇÁÀýº´(Áõ)ÁõÈıº
  • lymphoproliferative syndrome
    ¸²ÇÁ¼¼Æ÷Áõ½ÄÁõÈıº
  • middle lobe syndrome
    Áß°£¿±ÁõÈıº
  • milk-alkali syndrome
    ¿ìÀ¯¾ËÄ®¸®ÁõÈıº
  • morning glory syndrome
    ³ªÆÈ²ÉÁõÈıº
  • motor syndrome
    ¿îµ¿(ÁßÃß)ÁõÈıº
  • mucocutaneous lymph node syndrome
    Á¡¾×ÇǺθ²ÇÁÀýÁõÈıº
  • myasthenic syndrome
    ±Ù(À°)¹«·ÂÁõÈıº
  • Mallory-Weiss syndrome
    ¸»·Î¸®-¹ÙÀ̽ºÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • phantom lover syndrome
    ȯ»ó¿¬ÀÎÁõÈıº
  • pluriglandular syndrome
    ¹µ»ùÁõÈıº, ¿©·¯»ùÁõÈıº
  • positive and negative syndrome
    ¾ç¼ºÀ½¼ºÁõÈıº
  • post-infarction syndrome
    °æ»öÈÄÁõÈıº
  • postelectric shock syndrome
    Àü±âÃæ°ÝÈÄÁõÈıº
  • postencephalitic behavioral syndrome
    ³ú¿°ÈÄÇൿÁõÈıº
  • postmenopausal syndrome
    Æó°æÈÄÁõÈıº
  • postpartum mood syndrome
    »êÈıâºÐÁõÈıº
  • premenstrual syndrome
    ¿ù°æÀüÁõÈıº
  • presbyophrenia syndrome
    ³ëÀÎÄ¡¸Å
  • prodromal radiation syndrome
    Á¶Áü¹æ»ç¼±ÁõÈıº
  • prune-belly syndrome
    ¸»¸°´ëÃßÁõÈıº
  • psychomotor syndrome
    Á¤½Å¿îµ¿ÁõÈıº
  • punch-drunken syndrome
    (¢¡boxer¡¯s dementia) ±ÇÅõ¼±¼öÄ¡¸Å
  • quadrilateral space syndrome
    ³×¸ð°ø°£ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • acute retinal necrosis
    ±Þ¼º¸Á¸·±«»ç
  • acute rheumatic arthritis
    ±Þ¼º·ù¸¶Æ¼½º¼º °üÀý¿°
  • acute rheumatic arthritis<³ª> a. rheumatica acu ta
    ±Þ¼º ·ù¸¶Æ¼½º¼º °üÀý¿°.
  • acute rheumatic arthritis<³ª> a. rheumatica acuta
    ±Þ¼º ·ù¸¶Æ¼½º¼º °üÀý¿°.
  • acute rheumatic fever
    ±Þ¼º ·ù¸¶Æ¼½º¿­.
  • acute rheumatic polyarthritis
    ±Þ¼º ·ù¸¶Æ¼½º¼º ´Ù¹ß(¼º) °üÀý¿°(Ðáàõ¡­ÒýÛ¡àõÎ¼ï½æú).
  • acute rheumatic polyarthritis
    ±Þ¼º·ù¸¶Æ¼½º¼º ´Ù¹ß(¼º) °üÀý¿°
  • acute rheumatism
    ±Þ¼º ·ù¸¶Æ¼½ºÁúȯ.
  • acute rhinitis
    ±Þ¼º ºñ¿°
  • acute schizophrenic episode
    ±Þ¼º Á¤½ÅºÐ¿­º´Àû »ðÈ­
  • acute sialadenitis
    ±Þ¼º Ÿ¾×¼±¿°
  • acute sinusitis
    ±Þ¼º ºÎºñµ¿¿°
  • acute spasmodic laryngitis
    ±Þ¼º °æÁ÷(¼º) Èĵο°
  • acute stomach dilatation
    ±Þ¼º À§È®Àå(¡­êÖüªíå).
  • acute stress disorder
    ±Þ¼º ½ºÆ®·¹½º Àå¾Ö(º´)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • acute intermittent porphyria
    ±Þ¼º °£Ç漺 (¡­ÊàúÎàõ) Æ÷¸£ÇǸ®¾Æ(Áõ).
  • acute intermitternt porphyria
    ±Þ¼º °£Ç漺 Æ÷¸£ÇǸ®¾Æ(Áõ)
  • acute interstitial pneumonitis
    ±Þ¼º °£Áú¼º Æó·Å(¡­ÊàòõàõøËæú).
  • acute intussusception
    ±Þ¼º ÀåÁßø(Áõ).
  • acute labyrinthitis
    ±Þ¼º ¹Ì·Î¿°, ¡­³»ÀÌ¿°
  • acute lacunar tonsillitis
    ±Þ¼º ¼±¿ÍÆíµµ¿°
  • acute laryngitis
    ±Þ¼º Èĵο°
  • acute laryngotracheal trauma
    ±Þ¼º Èĵαâ°ü¿Ü»ó
  • acute laryngotracheobronchitis
    ±Þ¼º Èĵαâ°üÁö¿°
  • acute leukemia
    ±Þ¼º ¹éÇ÷º´(?ËÑÌ´ËÓ).
  • acute leukemia
    ±Þ¼º ¹éÇ÷º´(¡­ÛÜúìÜ»).
  • acute leukemia virus
    ±Þ¼º¹éÇ÷º´¹ÙÀÌ·¯½º
  • acute lobar nephronia
    ±Þ¼º ½Å¿±¿°
  • acute lymphangitis
    ±Þ¼º ¸²ÇÁ°ü¿°.
  • acute lymphatic leukemia =ALL
    ±Þ¼º ¸²ÇÁ¼º ¹éÇ÷º´(?ËÛËÑÌ´ËÓ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
TIA Transient Ischemic Attack; Temporary Interference with the blood supply to the brain
ABI ankle/brachial index; atherothrombotic brain infarct
BAQ brain-age quotient
BBB blood-brain barrier; blood buffer base; bundle-branch block
BBBD blood brain barrier disruption
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
VBR ventricle brain ratio
APRF 3/acute phase response factor
ARI 5--acute renal insufficiency
APACHE ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION
ALL Acute lymphoblastic leukemia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • autoerythrocyte sensitization syndrome
    ÀÚ°¡ ÀûÇ÷±¸ °¨ÀÛ ÁõÈıº
    ÁÖ·Î ÀþÀº ¿©ÀÚ¿¡°Ô º¼ ¼ö ÀÖ´Â ÀÚ¹Ý ¹ÝÀÀÀÇ ÀÏÁ¾À¸·Î ¿Ü»ó ¾øÀÌ ¶Ç´Â ºÒ¿ÏÀü ¿Ü»ó ÈÄ ½Åü¿¡ ÀÚ¿¬ÀûÀ¸·Î µ¿ÅëÀ» µ¿¹ÝÇÏ°í ¹Ýº¹ÇÏ¿© ´Üµ¶ ¶Ç´Â ´Ù¹ß¼º ¹Ý»ó ÃâÇ÷ÀÌ ³ªÅ¸³­´Ù. ¸¹Àº Áõ·Ê¿¡¼­ ÀûÇ÷±¸ ±¸¼º ¼ººÐ¿¡ ´ëÇÑ °ú¹Î¼ºÀÌ ¿øÀÎÀ¸·Î »ý°¢µÇ³ª, ¹éÇ÷±¸°¡ ¿øÀÎÀ¸·Î »ý°¢µÇ´Â ¿¹µµ ÀÖ´Ù. Á¤¼­Àû Àå¾Ö°¡ ¹ßº´ °á½Ç ÀÎÀÚ·Î º¸ÀδÙ.
  • Axenfeld syndrome
    ¾Ç¼¾ÆçÆ® ÁõÈıº
  • B-K mole syndrome
    B-K ¸ð¹Ý ÁõÈıº
  • Barters syndrome
    ¹ÙÅÍ ÁõÈıº
  • basal ganglion calcification syndrome
    ±âÀú ½Å°æÀý ¼®È¸È­ ÁõÈıº
  • battered child syndrome
    ÇÇÇÐ´ë¾Æ ÁõÈıº, ¾Æµ¿ Çдë ÁõÈıº, ¼Ò¾Æ Çдë ÁõÈıº
    ¾Æµ¿ÀÇ »À ¹× ¿¬ºÎ Á¶Á÷¿¡ ´Ù¼öÀÇ ¿Ü»ó¼º º´º¯À» ³ªÅ¸³»´Â °ÍÀ¸·Î¼­ Á¾Á¾ °æ¸·ÇÏ Ç÷Á¾À» ¼ö¹ÝÇÑ´Ù. ÀÌ·± º´º¯Àº º¸Åë ¼ºÀÎÀÇ °íÀÇÀûÀÎ °¡ÇØ¿¡ ÀÇÇØ »ý±ä´Ù. ºÎ¸ðµéÀÌ 3¼¼ ÀÌÇÏ Æ¯È÷ 1¼¼ ÀÌÇÏÀÇ À¯¾Æ¸¦ ¹«ºÐº°ÇÏ°Ô ¶§¸®°Å³ª ±âŸ ¹æ¹ýÀ¸·Î ÇдëÇÔÀ¸·Î½á ÀϾ´Â ½Åü Áõ»ó. ¹Ì±¹ÀÇ ¼Ò¾Æ°ú ÀÇ»ç H. ÄÍÇÁ µîÀÌ ¹Ì±¹ Àü¿ª¿¡ °ÉÃÄ Á¶»çÇÏ¿´À¸¸ç, 1962³âÀÌ·¡ ¼±Áø Á¦±¹¿¡ ³Î¸® ¾Ë·ÁÁø Çö»óÀÌ´Ù. ÁÖ·Î, ¨ç ÇÇÇÏ ÃâÇ÷, Àý»ó, È­»ó µîÀÇ ÇǺΠÁõ¼¼, ¨è Àü½ÅÀÇ °ñÀý, Å»±¸, ¨é µÎ°³³» ÃâÇ÷À̳ª °æ¸·ÇÏÇ÷Á¾, ¨ê Àå±â ÆÄ¿­ ¹× ³»ÃâÇ÷ µî º¹ºÎÀÇ ¼Õ»ó, ¨ë ¼ºÀå ¹ß´Þ ÀåÇØ µîÀ» º¼ ¼ö ÀÖ´Ù. À̰ÍÀº ¿À´Ã³¯ÀÇ ¼±Áø Á¦±¹ÀÇ ±Þ¼ÓÇÑ °¡Á¤ ºØ±« Çö»ó°ú °ü·ÃÇÏ¿© ÀϾ´Â Áõ¼¼ÀÌ´Ù. ºÎºÎ°£ÀÇ °¥µîÀÌ ±Ø½ÉÇØÁö¸é À̵éÀº ¼­·Î °£ÆíÇÏ°Ô Çì¾îÁ®¾ß ÇÑ´Ù°í »ý°¢Çϰí À̶§ ¾î¸°¾ÆÀ̵éÀÌ Àå¾Ö¹°À̶ó ¹Ï°Ô µÇ¾î ¾Æ¹« ÁË ¾ø´Â ¾ÆÀ̵éÀ» ¸¶±¸ ÆøÇàÇÏ´Â µîÀÇ ÇдëÇàÀ§°¡ ³ªÅ¸³­´Ù. Çд븦 °¡ÇÏ´Â ºÎ¸ðµéÀº Á¤¼­ÀûÀ¸·Î ¹Ì¼÷ÇÑ È÷½ºÅ׸® ¼º°ÝÀÚ, ¼ºÀû ºÒ°¨Áõ, °ø°Ý¼º ¼º°ÝÀÚ, ¾ËÄÚ¿Ã Áßµ¶ÀÚ, ¸Á»óÇüÀÇ Á¤½ÅºÐ¿­Áõ ȯÀÚ µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. À̶§ Çд븦 ¹ÞÀº ¾ÆÀ̵éÀº Á¤½Å ¹ß´Þ Àå¾ÖÁõ, ¹ÝÇ×Àû ¼º°Ý, °íÁýÀÌ ¼¾ Ç×¹®±âÀû °íÂøÁõ µîÀÇ Æ¯Â¡À» ³ªÅ¸³½´Ù. ÀÌ·¯ÇÑ Çö»óÀº Çѱ¹ÀÇ »çȸ ¹®È­¿¡¼­´Â ¾ÆÁ÷ Èñ±ÍÇÏÁö¸¸ ±Ù´ëÈ­, ÇÙ°¡Á·È­, ¿©±ÇÀÇ ½ÅÀå, ¾ËÄÚ¿Ã Àα¸ÀÇ Áõ°¡, »çȸÀû ½ºÆ®·¹½º ¿äÀÎÀÇ Áõ´ë·Î Á¡Á¡ Áõ°¡µÈ´Ù.
  • Bechet syndrome
    º£Ã¼Æ® ÁõÈıº
    º£Ã¼Æ® ÁõÈıºÀº ¹Ýº¹µÇ´Â ±¸°­ ¹× ¼º±âÀÇ ±Ë¾ç°ú ´« ¹× ÇǺΠµîÀ» ħ¹üÇÏ´Â ¿©·¯ ±â°ü¿¡ ¿À´Â ÁúȯÀÌ´Ù. ¾ÆÁ÷±îÁö È®½ÇÇÑ ¿øÀÎÀº ¸ð¸£Áö¸¸ Ç÷°ü¿°ÀÌ ÁÖµÈ º´¸® ¼Ò°ßÀ̰í ÀÚ°¡ Ç×ü°¡ 50%¿¡¼­ ÃâÇöÇÏ´Â °ÍÀ¸·Î º¸¾Æ¼­ ÀÚ°¡¸é¿ª ÁúȯÀÇ Çϳª¶ó°í »ý°¢Çϰí ÀÖ´Ù. Áõ»óÀÇ Á¤µµ´Â ½Ã°£ÀÌ °¡¸é ´úÇØÁö°í ½ÉÇÑ ÇÕº´ÁõÀÌ ¾ø´Â ÇÑ ¼ö¸í°ú´Â °ü°è°¡ ¾ø´Ù. ±×·¯³ª Ä¡·á´Â Ưº°ÇÑ °ÍÀÌ ¾ø°í ´ëÁõÀûÀÌ°í °æÇèÀûÀÎ Ä¡·á¸¦ ÇϰԵǾî Áõ»ó¿¡ µû¶ó¼­
  • Behcet's syndrome
    º£Ã¼Æ® ÁõÈıº, Behcet ÁõÈıº
    ±¸°­, ´«, ¼º±âÀÇ º´¼Ò°¡ Ư¡ÀΠƯ¹ß¼º Áúȯ. ´«¿¡¼­ º¼ ¼ö ÀÖ´Â ¼Ò°ßÀº Æ÷µµ¸·¿°, ¸Á¸·¿° ¹× °á¸·¿°À̰í, ¼º±â¿¡ ³ªÅ¸³ª´Â ¼Ò°ßÀº ´ë°³°¡ ÇÇºÎ¿Í Á¡¸·ÀÇ ±Ë¾çÀ̸ç, ±¸°­¿¡ ³ªÅ¸³ª´Â ¼Ò°ßÀº À¯»ç ¾ÆÇÁŸ¼º ±Ë¾çÀÌ´Ù. Áø´ÜÀº ÀÓ»ó ¼Ò°ß¿¡ ±Ù°ÅÇÑ´Ù. Ä¡·á¿¡´Â Àü½Å¼º ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å Åõ¿©¸¦ ÀÌ¿ë. À¯ÀüÀû ¿ä¼Ò°¡ ÀÖ´Ù°í º¸°íµÇ°í ÀÖ´Ù.
  • big heart syndrome
    °Å½É ÁõÈıº
  • black cardiac syndrome
    Èæ½ÉÀå ÁõÈıº
  • Boerhaave syndrome
    ºÆ¸£ÇϺ£ ÁõÈıº
    ±¸Åä·Î ÀÎÇØ ½ÄµµÀÇ ÀÚ¿¬ÀûÀÎ ÆÄ¿­À» ¸»Çϴµ¥ µ¿Åë°ú ¹ß¿­À» ¼ö¹ÝÇÑ °ß°©°ñ¾È ȤÀº Èä°ñÇÏ µ¿ÅëÀ» È£¼ÒÇÏ°í ¼îÅ© »óŰ¡ ¹ß»ýÇϱ⵵ ÇÑ´Ù. ±¤¹üÀ§ÇÑ ±«»ç¼º Á¾°Ýµ¿¿°Àº ÆíÃø ȤÀº ¾çÃø¼º ³óÈäÀ» ÃÊ·¡½Ã۱⵵ ÇÏ¿© 24~48½Ã°£³» »ç¸Á½Ã۱⵵ ÇÑ´Ù. ÀÓ»ó Áõ»óÀº ÈäºÎ X-¼± »çÁø»ó °æºÎ Á¶Á÷¸é°ú Á¾°Ýµ¿³» °ø±â°¡ ³ªÅ¸³ª°í Á¾°Ýµ¿ »óÀÌ È®´ëµÇ°í Á¾°Ýµ¿¿¡ ¾×¸é»ó°ú µå¹°°Ô ½É³¶°ú ÅëÇØ ½É³¶³» ¾×¸é»óÀÌ º¸À̱⵵ ÇÑ´Ù. ½Äµµ Á¶¿µ¼úµµ Áø´ÜÀÌ °¡´ÉÇÏ¸é °¡´ÉÇÑ ÇÑ ºü¸¥ Áø´Ü°ú Ä¡·á¸¸ÀÌ È¯ÀÚÀÇ »ýÁ¸À²À» ³ôÀÏ ¼ö ÀÖ´Ù.
  • bottle mouse syndrome
    ¿ìÀ¯º´ ¿ì½Ä
    Àå½Ã°£ ¿ìÀ¯¸¦ ¹°°í ÀÖ´Â À¯¾Æ¿¡ È£¹ß, ÇÏ¾Ç ÀýÄ¡¿¡´Â ¿ì½ÄÁõÀÌ ¾ø´Ù.
  • Briquets syndrome
    ºê¸®ÄÉ ÁõÈıº
    µ¿ÀǾî=ataxia syndrome. ºê¸®ÄÉ ¿îµ¿ ½ÇÁ¶ ÁõÈıº.
  • brittle hair syndrome
    Ãë¾à ¸ð¹ß ÁõÈıº
  • bronze baby syndrome
    ûµ¿»ö ¾Æ±â ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
leukaemia, erythroblastic, acute A myeloproliferative disorder characterised by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
(12 Dec 1998)
leukaemia, megakaryocytic, acute Nonlymphocytic leukaemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. Myelofibrosis or increased bone marrow reticulin is common.
(12 Dec 1998)
leukaemia, myelocytic, acute Progressive, malignant disease of the myeloid tissue in which the granular, polymorphonuclear leukocytes and their precursors predominate.
(12 Dec 1998)
leukaemia, nonlymphocytic, acute Acute leukaemia distinguished from acute lymphocytic leukaemia (all) by the morphology of the marrow and blood leukaemic cells. Cytoplasmic granules are usually present and the nucleus is usually large and irregular. Anll is more common in adults than all and occurs at any age.
(12 Dec 1998)
leukoencephalitis, acute haemorrhagic A rare, fatal postinfection or allergic demyelinating disease of the central nervous system having a fulminating course and occurring mainly in young adults. It is characterised by destruction of white matter to the point of liquefaction; widespread necrosis of blood vessel walls leading to the formation of multiple small haemorrhages in the involved areas and the exudation of fibrin into the surrounding tissue; and cellular infiltration of the necrotic areas.
(12 Dec 1998)
liver failure, acute A form of liver failure with rapid onset. It is often induced by the toxic effect of drugs and various toxic substances in experimental studies in animals and in clinical states in humans. If coma ensues, the constellation of neurological symptoms is referred to as hepatic encephalopathy.
(12 Dec 1998)
Aarskog-Scott syndrome A syndrome of ocular hypertelorism, anteverted nostrils, broad upper lip, saddle-bag scrotum, and laxity of ligaments resulting in genu recurvatum, flat feet, and hyperextensible fingers; X-linked and autosomal dominant forms.
Synonym: Aarskog-Scott syndrome.
(05 Mar 2000)
Aarskog syndrome <syndrome> Grier et al. (1983) reported father and 2 sons with typical Aarskog syndrome, including short stature, hypertelorism, and shawl scrotum.
They tabulated the findings in 82 previous cases. X-linked recessive inheritance has been repeatedly suggested. The family reported by Welch (1974) had affected males in 3 consecutive generations. Thus, there is either genetic heterogeneity or this is an autosomal dominant with strong sex-influence and possibly ascertainment bias resulting from use of the shawl scrotum as a main criterion. Stretchable skin was present in the cases of Grier et al. (1983). Teebi et al. (1993) reported the case of an affected mother and 4 sons (including a pair of monozygotic twins) by 2 different husbands. They suggested that the manifestations were as severe in the mother as in the sons and that this suggested autosomal dominant inheritance. Actually, the mother seemed less severely affected, compatible with X-linked inheritance.
Clinical signs: Mild to moderate short stature,normocephaly, Widow's peak hair, maxillary hypoplasia, broad nasal bridge, anteverted nostrils, long philtrum, broad upper lip, curved linear dimple below the lower lip, hypertelorism, ptosis, down-slanted palpebral fissures, ophthalmoplegia, strabismus, hyperopic astigmatism, large cornea, floppy ears, lop-ears,cleft lip/palate, shawl scrotum, saddle-bag scrotum, cryptorchidism, brachydactyly, digital contractures, clinodactyly, mild syndactyly, transverse palmar crease, lymphoedema of the feet, ligamentous laxity, osteochondritis dissecans, proximal finger joint hyperextensibility, flexed distal finger joints, genu recurvatum, flat feet, stretchable skin, cervical spine hypermobility, odontoid anomaly, macrocytic anaemia, hemochromatosis, hepatomegaly, portal cirrhosis, imperforate anus, rectoperineal fistula, interstitial pulmonary disease, sternal deformity.
Inheritance: Sex-influenced autosomal dominant form, also X-linked form.
(05 Aug 1998)
abdominal muscle deficiency syndrome <syndrome> Congenital absence (partial or complete) of abdominal muscles, in which the outline of the intestines is visible through the protruding abdominal wall; in males, genitourinary anomalies (urinary tract dilation and cryptorchidism) are also found; genetics unclear.
(05 Mar 2000)
abstinence syndrome <syndrome> A constellation of physiologic changes undergone by persons or animals who have become physically dependent on a drug or chemical due to prolonged use at elevated doses, but who are abruptly deprived of that substance. The abstinence syndrome varies with the drug to which dependence has developed. Generally the effects observed are in an opposite direction from those produced by the drug; e.g., the withdrawal syndrome from central nervous system depressants such as barbiturates and benzodiazepines consists of insomnia, restlessness, tremulousness, hallucinations, and, in the extreme, tonic-clonic convulsions which may prove fatal. The onset time and severity of the abstinence syndrome depend upon how rapidly the drug disappears from the body.
(05 Mar 2000)
Achard syndrome <syndrome> Arachnodactyly with small receding mandible, broad skull, and joint laxity limited to the hands and feet; genetics unclear.
(05 Mar 2000)
Achard-Thiers syndrome <syndrome> One form of a virilizing disorder of adrenocortical origin in women, characterised by masculinization and menstrual disorders in association with manifestations of diabetes mellitus, such as glucosuria.
(05 Mar 2000)
Achenbach syndrome <syndrome> Haematoma of the finger pad with accompanying oedema; of unknown cause in the absence of disturbances in blood coagulation mechanisms.
(05 Mar 2000)
achoo syndrome <syndrome> A disorder characterised by nearly uncontrollable paroxysms of sneezing provoked in a reflex fashion by the sudden exposure of a dark-adapted subject to intensely bright light, usually sunlight.
Inheritance: autosomal dominant.
(05 Aug 1998)
Acquired Immunodeficiency Syndrome <immunology, syndrome> An epidemic disease caused by an infection by human immunodeficiency virus (HIV-1, HIV-2), a retrovirus that causes immune system failure and debilitation and is often accompanied by infections such as tuberculosis. AIDS is spread through direct contact with bodily fluids.
Acronym: AIDS
(10 May 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
ÅëÇÕ°Ë»ö ¿Ï·á